Lucentis (ranibizumab) ABBREVIATED UK PRESCRIBING INFORMATION.
出版信息
Eye (Lond). 2017 Aug;31(S2):S18-S20. doi: 10.1038/eye.2017.149.
Abstract
摘要
相似文献
1
Lucentis (ranibizumab) ABBREVIATED UK PRESCRIBING INFORMATION.雷珠单抗（Lucentis，兰尼单抗）英国简略处方信息。
Eye (Lond). 2017 Aug;31(S2):S18-S20. doi: 10.1038/eye.2017.149.
2
Choroidal Thickness Changes After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration.玻璃体内注射雷珠单抗治疗渗出性年龄相关性黄斑变性后的脉络膜厚度变化。
BioDrugs. 2016 Aug;30(4):353-9. doi: 10.1007/s40259-016-0179-0.
3
Safety and efficacy of ranibizumab for pregnant women in idiopathic choroidal neovascularization.雷珠单抗治疗妊娠合并特发性脉络膜新生血管的安全性和有效性
Acta Ophthalmol. 2015 Nov;93(7):e597-8. doi: 10.1111/aos.12611. Epub 2014 Dec 7.
4
Safety and complications of intravitreal injections performed in an Asian population in Singapore.新加坡亚洲人群玻璃体内注射的安全性与并发症
Int Ophthalmol. 2017 Apr;37(2):325-332. doi: 10.1007/s10792-016-0241-4. Epub 2016 May 28.
5
HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.HORIZON：雷珠单抗治疗年龄相关性黄斑变性脉络膜新生血管的开放性扩展试验。
Ophthalmology. 2012 Jun;119(6):1175-83. doi: 10.1016/j.ophtha.2011.12.016. Epub 2012 Feb 4.
6
Same-day consecutive bilateral intravitreal injections of ranibizumab for the treatment of bilateral active choroidal neovascularization in age-related macular degeneration.雷珠单抗同日连续双侧玻璃体内注射治疗年龄相关性黄斑变性双侧活动性脉络膜新生血管
Acta Ophthalmol. 2012 Sep;90(6):e491-3. doi: 10.1111/j.1755-3768.2011.02327.x. Epub 2012 Jan 23.
7
RETICULAR PSEUDODRUSEN ARE NOT A PREDICTIVE FACTOR FOR THE 1-YEAR RESPONSE TO INTRAVITREAL RANIBIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.在新生血管性年龄相关性黄斑变性中，网状假性玻璃膜疣并非玻璃体内注射雷珠单抗1年疗效的预测因素。
Retina. 2017 Jan;37(1):53-59. doi: 10.1097/IAE.0000000000001134.
8
Ophthalmic Application of Anti-VEGF Therapy.抗血管内皮生长因子疗法的眼科应用
Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):479-480. doi: 10.22608/APO.2017500.
9
A Prospective Masked Clinical Assessment of Inflammation After Intravitreal Injection of Ranibizumab or Aflibercept.玻璃体内注射雷珠单抗或阿柏西普后炎症的前瞻性盲法临床评估
J Ocul Pharmacol Ther. 2016 May;32(4):216-8. doi: 10.1089/jop.2015.0152. Epub 2016 Mar 3.
10
Endothelial progenitor cells and plasma vascular endothelial growth factor and stromal cell-derived factor-1 during ranibizumab treatment for neovascular age-related macular degeneration.在雷珠单抗治疗新生血管性年龄相关性黄斑变性期间的内皮祖细胞和血浆血管内皮生长因子及基质细胞衍生因子-1。
J Ocul Pharmacol Ther. 2013 Jul-Aug;29(6):530-8. doi: 10.1089/jop.2012.0013. Epub 2013 Apr 10.
引用本文的文献
1
Early Miscarriage Occurring Six Days After Intravitreal Ranibizumab Injection.玻璃体内注射雷珠单抗六天后发生早期流产。
Med Hypothesis Discov Innov Ophthalmol. 2019 Summer;8(2):69-72.
Zotero 插件